Nest Genomics

Software to launch and integrate genetics into clinical care

New York, United States · Founded 2022

Headquarters
New York, New York
Employees
11–50
Founded
2022
Last Round
Series ANov 2025
Rounds
3

About

Nest is a lab-agnostic, comprehensive solution for organizations to launch and implement large-scale genomic programs. The platform includes the ability to triage, consent, and counsel patients for genetic testing, provide EMR-integrated clinical decision support for providers managing patients with genetic results, and manage patients’ clinical needs across the continuum of care.

Summary

Nest Genomics is a Digital Health company based in New York, United States, founded in 2022. Its most recent funding was a Series A round in Nov 2025. Investors include 8VC, BlueCross BlueShield Venture Partners and Amboy Street Ventures.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ANov 2025

Sign up to see all 3 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nest Genomics on Indexed.vc
<a href="https://indexed.vc/companies/nesthealth"><img src="https://indexed.vc/api/badge/company/nesthealth" alt="Nest Genomics on Indexed.vc" width="260" height="76" /></a>